These steps are in line with Endocrine Society recommendations. On April 10, the Biden-Harris Administration issued the first-ever national, legally enforceable drinking water standard to protect communities from exposure to harmful per-and polyfluoroalkyl substances (PFAS), also known as ‘forever chemicals.’ As part of the administration’s commitment to combatting PFAS, the Environmental Protection Agency (EPA) announced...
Three editors of the Journal of the Endocrine Society (JES) recently published an editorial titled “From Fundamentals to the Clinic: Advancing Obesity Research in Endocrinology,” recognizing that the landscape of obesity research has rapidly evolved in the past five years, and that sharing scientific data is an important step toward addressing the growing global obesity...
On April 13, the Endocrine Society and the Korean Endocrine Society (KES) officially entered into a memorandum of Understanding (MOU) during the 12th Seoul International Congress of Endocrinology and Metabolism (SICEM) in conjunction with the 43rd Annual Scientific Meeting of the KES, which took place in Seoul, South Korea, April 11 – 13, 2024. This...
TIME Magazine recently recognized three Endocrine Society members in its 100 Most Influential People of 2024: Daniel J. Drucker, MD, professor of medicine, University of Toronto, Toronto, Canada, editor-in-chief, Endocrine Reviews; Joel F. Habener, MA, MD, chief of Laboratory of Molecular Endocrinology, Massachusetts General Hospital; and Svetlana Mojsov, PhD, research associate professor at Rockefeller University in...
Like it or not, artificial intelligence (AI) is here to stay, and its impact on both the science and practice of endocrinology will soon be quite evident. The ENDO 2024 Plenary session, “Artificial Intelligence in Health and Biomedical Research: The Future Is Now,” will no doubt answer many questions on the minds of endocrinologists in...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Clinical Trial Interim Data Show Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome On April 11, Amylyx Pharmaceuticals announced interim data from the ongoing Phase 2 HELIOS clinical trial of AMX0035 (sodium phenylbutyrate [PB] and...
New research published in The Journal of Clinical Endocrinology & Metabolism finds a high prevalence of type D personalities among people with hypothyroidism. Hypothyroidism is a condition in which the thyroid gland does not produce enough thyroid hormones. Between 10-15% of people with treated hypothyroidism experience persistent symptoms despite achieving normal thyroid hormone levels, and...
Science has shown that virtually all of us are exposed to endocrine-disrupting chemicals (EDCs) essentially as soon as we’re born … and even before! The ENDO 2024 symposium “Endocrine-Disrupting Chemicals in Reproductive Endocrinology” looks at these impacts in three different sessions that look at EDCs prenatally, postnatally, and environmentally. When you head to Boston, Mass.,...
Three editors of the Journal of the Endocrine Society (JES) recently published an editorial titled “From Fundamentals to the Clinic: Advancing Obesity Research in Endocrinology,” recognizing that the landscape of obesity research has rapidly evolved in the past five years, and that sharing scientific data is an important step toward addressing the growing global obesity...
